Open AccessS2440 Ustekinumab for Treatment of Refractory Pyoderma Gangrenosum in a Crohn’s Disease Patient
Author(s) -
Kevin Groudan,
Rohit Singhania
Publication year - 2021
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.907
H-Index - 252
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/01.ajg.0000783292.24257.ad
Subject(s) - medicine , ustekinumab , pyoderma gangrenosum , crohn's disease , vedolizumab , adalimumab , dermatology , surgery , discontinuation , inflammatory bowel disease , colonoscopy , refractory (planetary science) , pimecrolimus , gastroenterology , tacrolimus , disease , cancer , colorectal cancer , transplantation , physics , astrobiology